{"nct_id":"NCT02130557","title":"A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2014-07-15","start_date_type":"ACTUAL","primary_completion_date":"2016-08-11","primary_completion_date_type":"ACTUAL","completion_date":"2020-04-17","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}